Clinical Scorecard: A Randomized Controlled Trial Comparing Conventional Oxygen Therapy, High-Flow Nasal Cannula, and Jet Ventilation Using the Wei Nasal Jet Tube During Bronchoscopic Procedures Under Deep Sedation

At a Glance

Key Highlights

• SJOV showed a lower incidence of intraoperative hypoxemia compared to conventional oxygen therapy (COT)
• Significantly higher PaO2 levels in the SJOV group than in COT and high-flow nasal cannula (HFNC) groups
• SJOV resulted in lower lactic acid levels compared to both COT and HFNC
• No significant differences in adverse events or procedure duration among the groups

Guideline-Based Recommendations

Diagnosis

• Assess airway stenosis via preoperative computed tomography (CT)
• Evaluate patient eligibility based on ASA classification II-III

Management

• Utilize SJOV for oxygenation and ventilation in patients with mild-to-moderate airway stenosis during bronchoscopy

Monitoring & Follow-up

• Monitor SpO2 and arterial blood gas parameters during procedures

Risks

• Consider exclusion criteria such as severe airway stenosis and comorbid conditions affecting anesthesia

Patient & Prescribing Data

Adults aged 18-80 with mild-to-moderate airway stenosis

SJOV is a feasible option for oxygenation without increasing adverse events

Clinical Best Practices

• Ensure informed consent is obtained from all participants
• Conduct thorough preoperative assessments to identify suitable candidates for SJOV
• Maintain hemodynamic stability and monitor for hypoxemia during procedures

Related Resources & Content

• Clinical Trial Registration